podcast about glp 1 GLP-1 Drugs - One Thing They Don't Reduce [Podcast] Vida’s VP of Clinical Strategy,
Description
22, 2025 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only and does not constitute medical advice
The gut microbiome is considered the most abundant pool of microorganisms, which release metabolic products that facilitate gut-brain signaling
Learn how smaller doses may support weight management and metabolic health.
![podcast about glp 1 GLP-1 Drugs - One Thing They Don't Reduce [Podcast] Vidas VP of Clinical Strategy,](https://static.wixstatic.com/media/2ab4f7_05c0bfe1cc024d9cb064d9396d8ecd5b~mv2.jpg/v1/fill/w_980,h_980,al_c,q_85,usm_0.66_1.00_0.01,enc_avif,quality_auto/2ab4f7_05c0bfe1cc024d9cb064d9396d8ecd5b~mv2.jpg)
(7:20) Why we made MAPS GLP-1
![podcast about glp 1 GLP-1 Drugs - One Thing They Don't Reduce [Podcast] Vidas VP of Clinical Strategy,](https://glp1studio.com/og-default.png)
PlexusDx GLP-1 medications qualify as FSA-eligible expenses, allowing you to use pre-tax dollars for your weight loss therapy
Experience better weight loss results and reduced side effects with our premium plant protein, specifically formulated for GLP-1 medication users
![podcast about glp 1 GLP-1 Drugs - One Thing They Don't Reduce [Podcast] Vidas VP of Clinical Strategy,](https://static.wixstatic.com/media/96c908_ade063d286564de0a759f3cc420f715e~mv2.png/v1/fill/w_1031,h_621,al_c/GLP1%20Shortages%20and%20Compoundin.png)